BSEGodavari Drugs LtdLowNeutral
Announced Mon, 23 Mar · 17:03 IST

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Priyanka Jaju, Mukund Kakani, Prashant Shrimal, ....

Ownership Changes View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+7.1%1-day move
₹84.00
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+7.1+1.8+2.4+11.9+9.5+8.3+45.4+37.0+51.2+48.4
Up moveDown movePending
AI summary

BSE has received a disclosure under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, filed by individuals including Priyanka Jaju, Mukund Kakani, and Prashant Shrimal. This regulation typically applies when a person holding more than 5% of a company's shares reports any further acquisition or disposal of shares. The full details of the disclosure (direction of trade, quantity, and percentage change) are not available because the linked BSE page returned a 'page moved' error. Without the actual filing, the nature of the transaction cannot be determined.

Likely market impact

No actionable impact can be assessed since the underlying disclosure document was inaccessible. Shareholders should monitor BSE corporate announcements for the full filing to understand whether this reflects buying or selling by key individuals.